RCE — Recce Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSucker Stock

Annual balance sheet for Recce Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	R2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	—	12 M	12 M	12 M	12 M
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	11.6	1.61	4.46	10.5	2.72
Net Total Accounts Receivable
Net Total Receivables	0.182	0.091	0.451	0.622	3.87
Prepaid Expenses
Total Other Current Assets
Total Current Assets	12.2	1.95	5.14	11.4	7.12
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.439	0.608	1.23	1.03	1.41
Other Long Term Assets
Total Assets	12.6	2.56	6.37	12.4	8.53
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.45	4.85	15.1	6.13	16.3
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.56	5.14	15.9	15.5	25.3
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	10.1	-2.59	-9.52	-3.05	-16.7
Total Liabilities & Shareholders' Equity	12.6	2.56	6.37	12.4	8.53
Total Common Shares Outstanding